Literature DB >> 23239353

Synaptic vesicle proteins: targets and routes for botulinum neurotoxins.

Gudrun Ahnert-Hilger1, Agnieszka Münster-Wandowski, Markus Höltje.   

Abstract

Synaptic vesicles (SV) are key organelles of neuronal communication. SV are responsible for the storage of neurotransmitters, which are released by Ca(2+)-dependent exocytosis. After release and interaction with postsynaptic receptors, transmitters rapidly diffuse out of the synaptic cleft and are sequestered by plasma membrane transporters (in some cases following enzymatic conversion). SVs undergo endocytosis and are refilled by specific vesicular transmitter transporters different in the various neuronal subtypes. Besides these differences, SVs in general are equipped with a remarkable common set of proteins. Botulinum neurotoxins (BoNTs) inhibit neurotransmitter release from almost all types of neurons by cleaving proteins required for membrane fusion localized either to SVs (synaptobrevin) or to the plasma membrane (SNAP-25 and syntaxin) depending on the BoNT serotype. To enter the neuronal cytoplasm, BoNTs specifically interact with the luminal domain of SV proteins (synaptotagmin or SV2, depending on serotype) transiently exposed during exocytotic membrane fusion and occurring in almost every neuron. Thus, the highly specific interaction with luminal domains of SV proteins commonly expressed on all SV types is one reason why BoNTs exhibit such a high neuronal specificity but attack almost every neuron type.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23239353     DOI: 10.1007/978-3-642-33570-9_8

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  11 in total

Review 1.  The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Authors:  Sergio Pantano; Cesare Montecucco
Journal:  Cell Mol Life Sci       Date:  2013-06-11       Impact factor: 9.261

2.  Isolation and quantification of botulinum neurotoxin from complex matrices using the BoTest matrix assays.

Authors:  F Mark Dunning; Timothy M Piazza; Füsûn N Zeytin; Ward C Tucker
Journal:  J Vis Exp       Date:  2014-03-03       Impact factor: 1.355

Review 3.  Cargo-delivery platforms for targeted delivery of inhibitor cargos against botulism.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

4.  Internalization of the Active Subunit of the Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin Is Dependent upon Cellugyrin (Synaptogyrin 2), a Host Cell Non-Neuronal Paralog of the Synaptic Vesicle Protein, Synaptogyrin 1.

Authors:  Kathleen Boesze-Battaglia; Lisa P Walker; Anuradha Dhingra; Konstantin Kandror; Hsin-Yao Tang; Bruce J Shenker
Journal:  Front Cell Infect Microbiol       Date:  2017-11-14       Impact factor: 5.293

5.  Autoantibodies to synapsin I sequestrate synapsin I and alter synaptic function.

Authors:  Anna Rocchi; Silvio Sacchetti; Antonio De Fusco; Silvia Giovedi; Barbara Parisi; Fabrizia Cesca; Markus Höltje; Klemens Ruprecht; Gudrun Ahnert-Hilger; Fabio Benfenati
Journal:  Cell Death Dis       Date:  2019-11-14       Impact factor: 8.469

6.  Tetanus insensitive VAMP2 differentially restores synaptic and dense core vesicle fusion in tetanus neurotoxin treated neurons.

Authors:  Rein I Hoogstraaten; Linda van Keimpema; Ruud F Toonen; Matthijs Verhage
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

Review 7.  SNAP-25, a Known Presynaptic Protein with Emerging Postsynaptic Functions.

Authors:  Flavia Antonucci; Irene Corradini; Giuliana Fossati; Romana Tomasoni; Elisabetta Menna; Michela Matteoli
Journal:  Front Synaptic Neurosci       Date:  2016-03-24

8.  Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin.

Authors:  Jasmin Weisemann; Daniel Stern; Stefan Mahrhold; Brigitte G Dorner; Andreas Rummel
Journal:  Toxins (Basel)       Date:  2016-05-17       Impact factor: 4.546

Review 9.  Botulinum Toxin A for Controlling Obesity.

Authors:  Raffaela Pero; Lorena Coretti; Francesca Lembo
Journal:  Toxins (Basel)       Date:  2016-09-26       Impact factor: 4.546

10.  Curcumin alleviates pain and improves cognitive impairment in a rat model of cobra venom-induced trigeminal neuralgia.

Authors:  Li Zhang; Xinli Ding; Zhe Wu; Min Wang; Ming Tian
Journal:  J Pain Res       Date:  2018-06-20       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.